Whitney Helms

Pharmacology Supervisor, OOD, CDER, FDA
Whitney Helms is a pharmacology supervisor in the Division of Hematology Oncology Toxicology for the team supporting the Division of Oncology 2 in CDER's Office of Oncologic Diseases at the FDA. She started at the Agency as a pharmacologist in the Division of Drug Oncology Products following a postdoctoral fellowship at UAB where she worked on Th17 cell commitment in the laboratory of Dr. Casey Weaver. Before moving to UAB, she completed her Ph.D. in immunology at UNC-Chapel Hill working on Galpha 13 pathway signaling in T cell development and activation.

My Speakers Sessions

Thursday, June 18

5:00pm EDT